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Abstract: Background: Sevoflurane postconditioning (SPostC) can exert myocardial protective effects similar to isch-
emic preconditioning. However, the exact myocardial protection mechanism by SPostC is unclear. Studies indicate 
that hypoxia-inducible factor-1 (HIF-1) maintains cellular respiration homeostasis by regulating mitochondrial respi-
ratory chain enzyme activity under hypoxic conditions. This study investigated whether SPostC could regulate the 
expression of myocardial HIF-1α and to improve mitochondrial respiratory function, thereby relieving myocardial 
ischemia-reperfusion injury in rats. Methods: The myocardial ischemia-reperfusion rat model was established using 
the Langendorff isolated heart perfusion apparatus. Additionally, postconditioning was performed using sevoflu-
rane alone or in combination with the HIF-1α inhibitor 2-methoxyestradiol (2ME2). The changes in hemodynamic 
parameters, HIF-1α protein expression levels, mitochondrial respiratory function and enzyme activity, mitochondrial 
reactive oxygen species (ROS) production rates, and mitochondrial ultrastructure were measured or observed. Re-
sults: Compared to the ischemia-reperfusion (I/R) group, HIF-1α expression in the SPostC group was significantly up-
regulated. Additionally, cardiac function indicators, mitochondrial state 3 respiratory rate, respiratory control ratio 
(RCR), cytochrome C oxidase (CcO), NADH oxidase (NADHO), and succinate oxidase (SUCO) activities, mitochondrial 
ROS production rate, and mitochondrial ultrastructure were significantly better than those in the I/R group. How-
ever, these advantages were completely reversed by the HIF-1α specific inhibitor 2ME2 (P<0.05). Conclusion: The 
myocardial protective function of SPostC might be associated with the improvement of mitochondrial respiratory 
function after up-regulation of HIF-1α expression.   
Keywords: Sevoflurane postconditioning, myocardial protective effect, hypoxia-inducible factor-1, mitochondrial 
respiratory function, respiratory enzyme activity
Introduction
Ischemic heart disease is a major cause of 
mortality due to human cardiovascular diseas-
es [1]. Restoration of the blood supply to the 
ischemic myocardia (i.e., reperfusion treat-
ment) is considered the most effective treat-
ment for myocardial ischemia. However, myo-
cardial reperfusion can aggravate or even 
cause an irreversible injury [2]. Therefore, de- 
velopment of methods that effectively reduce 
perioperative myocardial reperfusion injury is a 
current research topic. 
A large number of studies have indicated that 
inhalational anesthetics such as sevoflurane 
and isoflurane can relieve ischemia-reperfusion 
injury [3, 4]. Sevoflurane has been applied 
extensively in clinical practice and basic 
research due to its stable induction and rapid 
recovery pharmacological properties. Sevoflu- 
rane postconditioning (SPostC) can produce 
myocardial protective functions similar to isch-
emic preconditioning and is a promising treat-
ment against post-ischemic reperfusion injury 
during perioperative period [5]. Currently, the 
anti-reperfusion injury effect of SPostC is 
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thought to be achieved through protection of 
mitochondrial functions [6]; however, the exact 
mechanism has not been elucidated. As an 
important site for ATP production via oxidative 
phosphorylation, mitochondria play important 
roles in myocardial ischemia and reperfusion 
injury [7-9]. The structural integrity and normal 
functions of mitochondria are the bases for the 
maintenance of the physiological activities of 
the heart. Mitochondrial respiratory function 
and respiratory enzyme activity are the major 
components that reflect the oxidative phos-
phorylation process and structural integrity of 
the mitochondria. 
Hypoxia-inducible factor-1 (HIF-1) regulates the 
expression of a series of hypoxia-sensitive 
genes under hypoxic conditions to maintain the 
survival of tissues and cells. Studies have con-
firmed that HIF-1 is central to cardioprotection 
against ischemia-reperfusion injury [10]. 
Recent studies showed that HIF-1 maintained 
normal cellular respiration by regulating mito-
chondrial respiratory chain activity. Furth- 
ermore, HIF-1 can reduce the production of 
mitochondrial ROS to avoid cell injury [11]. 
Thus, we investigated whether the SpostC myo-
cardial protective function was associated with 
the regulation of myocardial mitochondrial 
respiratory function. 
We used an in vitro rat myocardial ischemia-
reperfusion injury model and studied the mech-
anism underlying the association between anti-
myocardial ischemia-perfusion by SPostC and 
HIF-1 by investigating mitochondrial respiratory 
function. 
Materials and methods
Animals and experimental groupings
A total of 88 healthy adult male Sprague-
Dawley (SD) rats with a body weight of 250-300 
g were provided by the experimental animal 
center of the Third Military Medical University 
(permission number SCXK2012-0005). All SD 
rats were raised according to the Guide for the 
Care and Use of Laboratory Animals released 
by the National Institute of Health of the USA 
(1996 revision).
These rats were randomly divided into 4 groups 
(n=22 rats/group) as follows: normal control (C) 
group, ischemia-reperfusion (I/R) group, SPo- 
stC group, and HIF-1α inhibitor (2-methoxye- 
stradiol, 2ME2) + SPostC (MSP) group. The C 
group received persistent perfusion of Krebs-
Henseleit (K-H) solution for 180 min. The I/R 
group was equilibrated for 20 min, followed by 
perfusion of 4°C St. Thomas cardioplegia; 
afterwards, the rats were perfused with K-H 
solution for 120 min, and then, whole heart 
ischemia was performed at 32°C for 40 min. 
The SPostC group was equilibrated for 20 min, 
followed by perfusion of 4°C St. Thomas car-
dioplegia. Afterwards, the rats were perfused 
with 1.0 MAC (minimum alveolar concentration) 
of sevoflurane-saturated K-H solution for 15 
min, and then, whole heart ischemia was per-
Figure 1. The schematic diagram of the isolated rat heart experimental procedures. With the exception of the C 
group, all hearts were equilibrated for 20 min, followed by whole heart ischemia for 40 min and reperfusion for 120 
min. The SpostC received 1.0 MAC sevoflurane treatment for 15 min, followed by reperfusion for 105 min. T1: the 
end of equilibration; T2: the end of reperfusion.
Sevoflurane postconditioning and myocardial protective effect
4417 Am J Transl Res 2016;8(10):4415-4424
formed for 40 min at 32°C, followed by continu-
ous perfusion of K-H solution for 105 min. The 
MSP group was perfused with 2ME2 (2 µM) + 
1.0 MAC of sevoflurane-saturated K-H solution 
for 15 min after 40 min of whole heart isch-
emia followed by continuous perfusion of K-H 
solution for 105 min (Figure 1). The preparation 
of 1.0 MAC of sevoflurane-saturated K-H was 
previously described [12, 13]. The sevoflurane 
concentration was monitored using a ULT-
Svi-22-07 gas detector (Division, Finland) and 
an infrared gas analyzer (Datex-Ohmeda, GE 
Healthcare) to ensure that the sevoflurane con-
centration in the K-H solution was maintained 
at 1.0 MAC. 
Establishment of the Langendorff model [14]
The rats were intraperitoneally injected with 
sodium pentobarbital (40 mg/kg) and heparin 
(250 U/kg). After anesthetization, the heart 
was rapidly removed (3-4 mm of the aorta was 
retained) and placed in K-H buffer pre-cooled 
to 4°C to discharge all blood in the heart cavi-
ties. The K-H buffer solution (mmol/L) was pre-
pared with NaCl (118), KCl (4.7), MgS04•7H20 
(1.2), KH2PO (1.2), NaHCO3 (25), glucose (11), 
and CaCl2 (2.5) at pH 7.45. The heart was 
immobilized with a Langendorff perfusion nee-
dle using a No. 4 surgical thread. Retrograde 
perfusion of the aorta was performed at 37°C 
using K-H solution equilibrated in 95% O2-5% 
CO2 mixed gas under 5.8 kPa perfusion pres-
sure. The pulmonary artery and left atrial 
appendage were cut open; then, a pressure 
measuring tube with a rubber balloon was 
inserted into the left ventricle through the 
mitral valve opening and connected with a bio-
logical function experimental pressure trans-
ducer system. The perfusion pressure was 
maintained at approximately 60-70 mmHg. The 
size and position of the balloon was adjusted to 
maintain the left ventricular end-diastolic pres-
sure (LVEDP) at 0-10 mmHg. The above steps 
were completed within 2 min. The inclusion cri-
teria were a heart rate (HR) >250 beats/min 
and a left ventricular developed pressure 
(LVDP) >80 mmHg after the isolated heart was 
equilibrated for 20 min. 
Monitoring of hemodynamics
The heart rate (HR, beats/min), LVDP (mmHg), 
LVEDP (mmHg), and maximum rate of increase 
of LV pressure (+dp/dtmax, mmHg/s) at the 
end of equilibration (T1) and the end of reperfu-
sion (T2) were collected using the Powerlab/8SP 
data collection system.
Measurement of mitochondrial respiratory 
function 
Myocardial mitochondria were extracted, and 
mitochondrial proteins were quantitated. 
Mitochondrial respiratory function was mea-
sured using a Clark oxygen electrode [15, 16]. 
The total volume of the reaction solution was 1 
mL, and the temperature was 37°C. First, 900 
μL of the mitochondrial respiration measure-
ment medium was added; after equilibration 
for 15 min, 50 μL of the mitochondrial suspen-
sion at a final concentration of 1 mg/mL was 
added, and the 20-30 sec oxygen consumption 
curve was recorded. After the curve was stabi-
lized, 10 μL of succinic acid (final concentration 
5 mM) and 1 μL of rotenone (final concentra-
tion 2 μM) were added. After state 4 respiration 
was entered, the results was recorded for 1 
min. Next, 9 μL of ADP (final concentration 100 
μM) was added to induce state 3 respiration. 
The changes in the oxygen consumption curve 
were recorded; when all of the ADP was com-
pletely phosphorylated to ATP, the mitochon-
dria entered state 4 respiration. Mitochondrial 
respiratory control rate (RCR) = the oxygen con-
sumption rate in state 3 respiration/the oxygen 
consumption rate in state 4 respiration. 
Measurement of mitochondrial respiratory 
enzyme activity [15, 17]
Extracted and quantitated mitochondria were 
repeatedly frozen and thawed at -80°C and 
20°C to prepare the mitochondrial subunits. 
The mitochondrial respiratory chain enzyme 
activities, including that of cytochrome C oxi-
dase (CcO), NADH oxidase (NADHO), and succi-
nate oxidase (SUCO), were measured. The total 
volume of the reaction solution was 1 mL, and 
the temperature was 37°C. The CcO measure-
ment medium, NADHO measurement medium, 
and SUCO measurement medium were added 
(900 μL each) and equilibrated for 15 min. The 
mitochondrial subunit suspension preparation 
(50 μL) was added, and the 5-10 min oxygen 
consumption curves were recorded.  
Measurement of the mitochondrial ROS pro-
duction rate
The myocardial mitochondrial ROS production 
rate was measured using fluorescence spec-
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trometry [18]. The basic principle is that dichlo-
rodihydrofluorescein diacetate (DCFH-DA) can 
diffuse through the mitochondrial membrane 
and form reduced dichlorodihydrofluorescein 
(DCFH), which does not exhibit fluorescence 
activity because of hydrolysis by esterases in 
the mitochondria. DCFH is rapidly oxidized by 
ROS into the highly fluorescent active sub-
stance dichlorofluorescein (DCF). The speed of 
the oxidization of DCFH into DCF positively cor-
relates with the ROS production rate. In this 
experiment, we used the 3 mL cuvette reaction 
system with 2.9 mL of mitochondrial ROS mea-
surement medium and 0.5 mg of mitochondria; 
we also included one cuvette that did not con-
tain mitochondria. Succinic acid at a final con-
centration of 3.3 mmol/L was added and used 
as the substrate; then, 3 μL of DCFH-DA at a 
final concentration of 5 mmol/L was added and 
incubated at 37°C for 15 min. The fluorescence 
intensity of the substrate without mitochondria 
(F1) and the fluorescence intensity of the sam-
ple with mitochondria (F) were measured. The 
ROS production rate was the result of subtract-
ing F1 from F. 
Myocardial ultrastructure 
After reperfusion, myocardial tissues with sizes 
of 1 mm×1 mm×1 mm were collected from 
each group. The ultrastructure of the myocar-
dial mitochondria were observed using a trans-
Figure 2. The cardiac function indicators at the end of equilibration (T1) and the end of reperfusion (T2). A: HR; 
B: LVDP; C: LVEDP; D: +dp/dtmax. Data are presented as the mean ± SEM (n=22). *P<0.05 vs T1; T2 time point: 
^P<0.05 vs C, #P<0.05 vs I/R, &P<0.05 vs SPostC.
Figure 3. The changes in the HIF-1α protein levels 
at the end of reperfusion. Data are presented as 
the mean ± SEM (n=6). *P<0.05 vs I/R; #P<0.05 vs 
SPostC.
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mission electron microscope after fixation, 
washing, dehydration, embedding, sectioning, 
and staining. 
Western blot analysis  
After the repeated reperfusion, the left ventric-
ular myocardial tissues were cut (n=6) and 
immediately placed in liquid nitrogen for stor-
age. Total proteins were extracted from the 
myocardial tissues and lysed in tissue lysis buf-
fer. Samples containing 30 µg of protein were 
subjected to SDS-PAGE and then transferred 
onto a membrane. After the membrane was 
blocked at 37°C for 2 h, an HIF-1α primary anti-
body was added at a 1:1000 dilution and incu-
bated at 4°C overnight. The membrane was 
washed with TBST and then incubated with an 
HRP-labeled secondary antibody at a 1:5000 
dilution at room temperature for 1 h. The imag-
es were developed using electrochemilumines-
cence (ECL). Analysis of the gray density values 
of the target protein bands was performed us- 
ing the Quantity One imaging analysis system.
Statistical analysis 
SPSS 17.0 statistical software was used for the 
data analysis. Measurement data are present-
ed as the mean ± standard error of the mean 
(SEM). The within group comparisons were per-
formed using the analysis of variance of repeat-
ed measurement design. The comparison bet- 
ween groups was performed using univariate 
analysis of variance. P<0.05 indicated that the 
difference had statistical significance. 
Results
Cardiac function indicators
No significant differences were detected in the 
HR, LVDP, LVEDP, and +dp/dtmax between 
groups at the end of equilibration (P>0.05). The 
(P<0.05). However, none of the cardiac function 
indicators between the SPostC and I/R groups 
were significantly different after the application 
of the HIF-1α inhibitor (P>0.05) (Figure 2A-D).  
Expression of the HIF-1α protein
Compared to the I/R group, myocardial HIF-1α 
expression in the SPostC group at the end of 
reperfusion was significantly up-regulated. 
Compared to the SPostC group, HIF-1α protein 
expression in the MSP group at the end of 
reperfusion was significantly down-regulated 
(P<0.05); however, no significant difference 
was detected in HIF-1α protein expression 
between the MSP and I/R groups (P>0.05) 
(Figure 3).
Mitochondrial respiratory function
The mitochondrial state 3 respiration and RCR 
did not significantly differ at the end of equili-
bration among all groups (P>0.05). The mito-
chondrial state 3 respiration and RCR at the 
end of reperfusion were significantly decreased 
in all groups compared to the end of equilibra-
tion (P<0.05). The comparison of all groups at 
the end of reperfusion showed that the mito-
chondrial state 3 respiration and RCR in the 
SPostC group were significantly increased com-
pared to those in the I/R group (P<0.05); no 
significant difference in respiration function 
was observed between the MSP and I/R groups 
(P>0.05) (Table 1). 
Mitochondrial respiratory enzyme activity
The CcO, NADHO, and SUCO activities at the 
end of equilibration did not significantly differ 
among groups (P>0.05). The CcO, NADHO, and 
SUCO activities at the end of reperfusion were 
significantly decreased in all groups compared 
to the activities at the end of equilibration 
Table 1. The changes in mitochondrial state 3 respiration and 
RCR at the end of equilibration (T1) and at the end of reperfu-
sion (T2). Data are presented as the mean ± SEM (n=6)
T1 T2
State 3 RCR State 3 RCR
Control 147.31±5.42 2.43±0.09 145.23±7.59 2.24±0.14*
I/R 145.05±8.33 2.35±0.17 70.16±5.99*,^ 1.11±0.09*,^
SpostC 146.46±5.11 2.34±0.19 121.94±6.24*,^,# 1.87±0.07*,^,#
MSP 147.47±7.91 2.36±0.14 71.02±5.29*,^,& 1.14±0.08*,^,&
*P<0.05 vs T1; T2 time point: ^P<0.05 vs C, #P<0.05 vs I/R, &P<0.05 vs 
SPostC.
HR, LVDP, and +dp/dtmax in all 
groups were significantly decre- 
ased at the end of reperfusion 
compared to the end of equilibra-
tion, whereas LVEDP was signifi-
cantly increased (P<0.05) (Figure 
2A-D). The comparison of all 
groups at the end of reperfusion 
showed that LVEDP was signifi-
cantly decreased and HR, LVDP, 
and +dp/dtmax were significantly 
increased in the SPostC group 
compared to the I/R group 
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(P<0.05). The comparison of all groups at the 
end of reperfusion showed that the CcO, 
NADHO, and SUCO activities in the SPostC 
group were significantly increased compared to 
those in the I/R group; however, the CcO, 
NADHO, and SUCO activities did not significant-
ly differ between the MSP and I/R groups 
(P>0.05) (Table 2). 
Mitochondrial ROS production rates
The mitochondrial ROS production rates in all 
groups at the end of reperfusion were signifi-
cantly increased compared to the rates at the 
end of equilibration. The mitochondrial ROS 
production rate at the end of reperfusion in the 
SPostC group was significantly lower than the 
rate in the I/R group. After the application of 
the HIF-1α inhibitor, the ROS production rates 
were not significantly different between the 
MSP and I/R groups (P>0.05) (Table 3).
Ultrastructure of myocardial mitochondria
In the C group, the myofilaments typically exhib-
ited an ordered arrangement with no obvious 
dissolution or fractures; the morphology of the 
mitochondria was intact with a round or oval 
shape and an orderly arrangement, and the 
cristae were closely connected. In the I/R 
group, the myocardial structure was severely 
damaged, with the myofilaments dissolved or 
even fractured; the mitochondria were signifi-
cantly swollen, the crista space was widened 
and broken, and the sarcoplasmic reticulum 
was highly expanded. In the SPostC group, the 
myofilaments exhibited an ordered arrange-
ment; some myofilaments and sarcomere spac-
es were widened and dissolved, but the major-
ity of the mitochondria had an intact morphology 
with clear and visible cristae. Conversely, some 
mitochondria were slightly swollen but did not 
exhibit dissolutions and ruptures. In the MSP 
group, the myocardial structure was damaged, 
the myofilaments were dissolved, and the mito-
chondria were significantly swollen (Figure 4).  
Discussion
Our study showed that SPostC significantly up-
regulated HIF-1α protein expression when com-
pared to the I/R group, improved mitochondrial 
respiratory function and mitochondrial respira-
tory enzyme activity, and relieved ischemia-
reperfusion injury. However, the myocardial 
protection effect of SPostC completely disap-
peared after the application of the HIF-1α inhib-
itor. This suggested that the myocardial protec-
tion effect of SPostC might be associated with 
the improvement of mitochondrial respiratory 
function after the up-regulation of HIF-1α 
expression. 
As a representative inhalational anesthetic, 
sevoflurane has been applied extensively in 
clinical practice. Compared to other volatile 
anesthetics, sevoflurane not only produces 
excellent anesthetic effects but also plays 
important protective roles in the perioperative 
myocardial ischemia-reperfusion process; th- 
erefore, it is considered as the choice of selec-
tion when defending the perioperative myocar-
Table 2. The changes in mitochondrial CcO, NADHO, and SUCO activities at the end of equilibration 
(T1) and at the end of reperfusion (T2). Data are presented as the mean ± SEM (n=6)
T1 T2
NADHO CcO SUCO NADHO CcO SUCO
C 316.56±13.93 97.39±5.75 101.85±5.73 287.19±12.84* 81.10±7.53* 80.88±6.12*
I/R 313.20±12.62 94.27±4.31 99.57±6.36 205.11±11.05*,^ 47.73±3.97*,^ 46.90±3.40*,^
SpostC 311.07±14.12 97.18±6.66 99.10±6.84 252.82±12.34*,^,# 69.07±4.45*,^,# 66.95±5.41*,^,#
MSP 310.60±11.35 96.85±5.44 100.43±6.24 209.27±9.65*,^,& 48.95±3.39*,^,& 48.95±3.39*,^,&
*P<0.05 vs T1; T2 time point: ^P<0.05 vs C, #P<0.05 vs I/R, &P<0.05 vs SPostC.
Table 3. The mitochondrial ROS production 
rates (RPR) at the end of equilibration (T1) 
and at the end of reperfusion (T2). Data are 
presented as the mean ± SEM (n=6)
T1 T2





*P<0.05 vs T1; T2 time point: ^P<0.05 vs C, #P<0.05 vs 
I/R, &P<0.05 vs SPostC.
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dial ischemia-reperfusion injury. Our results 
showed that LVDP, +dp/dtmax, and HR were sig-
nificantly increased at the end of reperfusion in 
the SPostC group compared to the I/R group, 
which was consistent with the results of 
Inamura et al [19]. Currently, the function of 
SPostC in the improvement of cardiac functions 
in the ischemic heart is thought to be associat-
ed with its maintenance of normal mitochon-
drial structure and function [20, 21]. 
The mitochondrion is the key organelle that pro-
vides energy to the myocardia. During isch-
emia-reperfusion, mitochondrial structures 
and mitochondrial respiratory functions are 
damaged, causing a reduction in ATP synthesis 
that further aggravates myocardial injury [22, 
23]. Previous studies confirmed that HIF-1 
plays a critical role in the defense against myo-
cardial ischemia-reperfusion injury [10]. Upon 
treatment with the HIF-1α-specific inhibitor 
2ME2, HIF-1α levels after ischemia-reperfusion 
in isolated hearts were significantly lower than 
those in the ischemia-reperfusion only group 
and were comparable to the levels in the non-
ischemic heart group [24]. Under hypoxic condi-
tions, up-regulation of HIF-1α expression not 
only regulates energy production by the mito-
chondrial respiratory chain and maintains CcO 
activities but also reduces ROS production 
from the mitochondria to avoid myocardial inju-
ry [11].
HIF-1 is the most important transcription factor 
involved in the transcriptional regulation of 
hypoxic responses. HIF-1 is a heterodimer that 
is primarily composed of the HIF-1α and HIF-1β 
subunits. Under normal oxygen conditions, pro-
lyl hydroxylase (PHD) and factor inhibiting HIF 
(FIH) in normal cells use oxygen as the sub-
Figure 4. The changes in the myocardial ultrastructure in the left ventricle at the end of reperfusion (n=4). The 
magnification is 10,000×. 
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strate to hydroxylate the HIF-1α protein in the 
cytoplasm. Then, the hydroxylated HIF-1α is 
ubiquitinated by the E3 ubiquitin ligase com-
plex von Hippel-Lindau (VHL) and degraded 
through the ubiquitin-proteasome degradation 
pathway. Under hypoxic conditions, PHD and 
FIH are suppressed and HIF-1α degradation is 
blocked. A large number of HIF-1α proteins 
accumulate and are translocated into the 
nucleus to form heterodimers with HIF-1β to 
produce active HIF-1. HIF-1 interacts with 
hypoxia response elements to regulate down-
stream target gene expression, which is condu-
cive to cell survival under hypoxic conditions 
[25]. 
In this study, to confirm whether the myocardial 
protective function of SPostC was associated 
with the maintenance of mitochondrial respira-
tory function after HIF-1 up-regulation, we mea-
sured the HIF-1α protein expression level. The 
results showed that HIF-1α protein expression 
was significantly increased in the SPostC group 
and the mitochondrial state 3 respiration, RCR, 
and mitochondrial respiratory chain enzyme 
activities (CcO, NADHO, and SUCO) were signifi-
cantly better than those in the I/R group. 
Moreover, the mitochondrial ultrastructure in 
the SPostC was more intact and the ROS pro-
duction rate was significantly lower than that in 
the I/R group. To validate the experimental 
results, we applied the HIF-1α inhibitor 2ME2 
and found that the above advantages of SPostC 
disappeared completely. Therefore, our results 
suggested that the myocardial protective func-
tion of SPostC might be due to the up-regula-
tion of HIF-1α expression by improving mito-
chondrial respiratory function, thereby relieving 
myocardial ischemia-reperfusion injury.
The study conducted by Sirvinskas et al also 
found that the application of sevoflurane during 
coronary artery bypass grafting surgery pro-
tected the myocardial mitochondrial outer 
membrane from ischemia-reperfusion injury 
and avoided the loss of CcO [26]. However, the 
researchers did not identify the pathway used 
by sevoflurane to protect the integrity of mito-
chondrial structure and function. In this study, 
we hypothesized that SPostC could reduce ROS 
release by the mitochondria to avoid injury to 
the mitochondrial membrane system through 
the up-regulation of HIF-1α expression [27, 28] 
thereby maintaining normal mitochondrial 
respiratory chain operations to provide energy 
for the restoration of cardiac function after 
myocardial ischemia-reperfusion; alternatively, 
SPostC could increase the nuclear transloca-
tion and expression of HIF-1α to promote the 
binding between HIF-1α and HIF-1β to form 
active HIF-1, which in turn could promote the 
expression of downstream target genes, pro-
mote mitochondrial respiration, and maintain 
mitochondrial enzyme activity, thereby relieving 
myocardial ischemia-reperfusion injury. 
Conclusion
Our study showed that SPostC up-regulated 
HIF-1α expression in the rat myocardia, 
improved mitochondrial respiratory function 
during myocardial ischemia-reperfusion, and 
maintained normal mitochondrial electron 
transport chain function, thereby relieving myo-
cardial ischemia-reperfusion injury in rats. This 
study will provide theoretical support for the 
mechanism underlying the myocardial protec-
tion by SPostC.
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